Position history for BlackRock, Inc.'s holdings in MONTE ROSA THERAPEUTICS INC
BlackRock, Inc. holds 5.6M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $92.7M as of 2026-Q1. The position was increased (+34.8% shares). GLUE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$92.7M
Current Shares
5.6M
Total Value Change
+$66.1M
Total Shares Change
+1.8M
Other major holders of GLUE: BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC
Increased |
| 5.6M |
+34.8% |
| $92.7M |
| 0.0% |
| $17.96 |
39 |
| 2025-Q4 | Increased | 4.2M | +9.6% | $65.6M | 0.0% | $15.97 | 32 |
| 2025-Q3 | Decreased | 3.8M | -0.8% | $28.3M | 0.0% | $7.31 | 0 |
| 2025-Q2 | Increased | 3.8M | +2.1% | $17.3M | 0.0% | $4.60 | 29 |
| 2025-Q1 | Decreased | 3.8M | -1.9% | $17.5M | 0.0% | $5.10 | 0 |
| 2024-Q4 | New | 3.8M | - | $26.7M | 0.0% | $7.02 | 40 |